Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial
Top Cited Papers
- 1 November 2005
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 366 (9497), 1622-1632
- https://doi.org/10.1016/s0140-6736(05)67661-1
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Expert consensus document on ?-adrenergic receptor blockersThe Task Force on Beta-Blockers of the European Society of CardiologyEuropean Heart Journal, 2004
- Task Force on Sudden Cardiac Death of the European Society of CardiologyEuropean Heart Journal, 2001
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction Towards an understanding of factors influencing clinical practiceEuropean Heart Journal, 1998
- Early and 1-year survival rates in acute myocardial infarction complicated by cardiogenic shock: A retrospective study comparing coronary angioplasty with medical treatmentAmerican Heart Journal, 1995
- Cardiogenic ShockThe New England Journal of Medicine, 1994
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsThe Lancet, 1994
- Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute mycardial infarction receiving thrombolytic therapyJournal of the American College of Cardiology, 1993
- Racial Differences in Drug ResponseThe New England Journal of Medicine, 1989
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985